一种新型的基于双过碘酸合镍（IV）的化学发光体系用于测定肾上腺素。
A novel chemiluminescence system with diperiodatonickelate (IV) for the determination of adrenaline.
机构信息
Chemical Synthesis and Pollution Control Key Laboratory of Sichuan Province, College of Chemistry and Chemical Engineering, China West Normal University, Nanchong, Sichuan 637002, China.
Chemical Synthesis and Pollution Control Key Laboratory of Sichuan Province, College of Chemistry and Chemical Engineering, China West Normal University, Nanchong, Sichuan 637002, China.
出版信息
Spectrochim Acta A Mol Biomol Spectrosc. 2014;121:288-91. doi: 10.1016/j.saa.2013.10.094. Epub 2013 Nov 1.
A novel chemiluminescence (CL) system with diperiodatonickelate (IV) (DPN) was developed for the determination of adrenaline for the first time. The possible CL emission mechanism was briefly discussed by comparing the fluorescence emission spectra with CL spectra. Under the optimum conditions, the relative CL intensity was linear over the concentration of AD ranging from 1.0×10(-7) to 1.0×10(-5) g mL(-1) with a detection limit of 4.0×10(-8) g mL(-1) (3σ). And the relative standard deviation was 3.7% for 2.0×10(-6) g mL(-1) AD (n=11). The developed method has been successfully applied to the determination of AD in pharmaceutical preparations.
一种新型的化学发光（CL）体系，使用双过碘酸盐合镍（IV）（DPN），首次被开发用于测定肾上腺素。通过比较荧光发射光谱和 CL 光谱，简要讨论了可能的 CL 发射机制。在最佳条件下，AD 的浓度在 1.0×10(-7) 到 1.0×10(-5) g mL(-1) 之间，相对 CL 强度呈线性关系，检测限为 4.0×10(-8) g mL(-1)（3σ）。对于 2.0×10(-6) g mL(-1) AD（n=11），相对标准偏差为 3.7%。该方法已成功应用于药物制剂中 AD 的测定。
Zotero 插件